WH Add to watchlist $77.63 +0.44 (+0.57%) Last updated: Jul 15, 2026 04:25
52-Week Range
$77.63
$69.21 $77.63 $92.69

Fundamentals Overview

Wyndham Hotels & Resorts, Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 30.5 P/B 13.09 P/S 4.04

Intrinsic value (DCF)

+40.9% upside vs price

Profitability

Net margin 13.4%

Risk (Beta)

0.63 — lower vol

Earnings & growth

EPS $2.55 Rev -2.1% Profit +201.7% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 60% confidence Risk: Lower Volatility — Beta 0.63. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +40.9% upside vs price · Analyst grade: B-

Pressures (Sell):

3M vs S&P 500: -19.2% · 3M vs Consumer Cyclical sector: -11.4%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$5.81B
P/E (TTM)
30.49
EPS (TTM)
$2.55
Dividend Yield
2.16%
52-Week Range
$69.21 - $92.69
Volume vs Avg
N/A
Beta
0.63

About

Wyndham Hotels & Resorts, Inc. functions internationally as a prominent hotel franchisor. Its business activities are primarily structured around two segments: Hotel Franchising and Hotel Management. Through Hotel Franchising, the company grants licenses for its diverse lodging brands and extends a range of associated services to independent hotel proprietors and other entities. Conversely, its Hotel Management segment delivers comprehensive management services for both full-service and limited-...
Sector: Consumer Cyclical
Headquarters: US
Employees: 2,000
IPO Date: May 2018
Beta: 0.63 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B-. Recent institutional grades: mixed. Current institutional positions: Buy: 7, Neutral: 4, Outperform: 5, Overweight: 14.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $109.35; current price is $77.63. That’s a +40.9% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 30.49
DCF value (model) $109.35 (40.9% upside)
PEG (TTM) N/A
P/B (TTM) 13.09
P/S (TTM) 4.04
P/FCF (TTM) 19.12
Liquidity & enterprise
Current Ratio (TTM) 0.33
Quick Ratio (TTM) 0.33
Cash Ratio (TTM) 0.07
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 13.4%
Gross margin (TTM) 55.69%
Operating margin (TTM) 28.82%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for WH.

Analyst Sentiment at a Glance

B- Sentiment Mixed
Buy 7Neutral 4Outperform 5Overweight 14
1 upgrade, 1 downgrade
Price Target Consensus
Current $77.63
Median $98.50
Consensus $97.50
Low consensus $87.00
High consensus $108.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Morgan Stanley maintain Overweight Overweight 2026-05-12
Susquehanna maintain Neutral Neutral 2026-05-04
Susquehanna maintain Neutral Neutral 2026-04-23
JP Morgan maintain Overweight Overweight 2026-04-21
Barclays maintain Overweight Overweight 2026-04-16
Morgan Stanley maintain Overweight Overweight 2026-04-10
Truist Securities maintain Buy Buy 2026-03-26
Morgan Stanley maintain Overweight Overweight 2026-03-10
Mizuho maintain Outperform Outperform 2026-02-20
Truist Securities maintain Buy Buy 2026-02-03
JP Morgan maintain Overweight Overweight 2026-02-03
Stifel maintain Buy Buy 2026-01-28
Barclays maintain Overweight Overweight 2026-01-16
Morgan Stanley maintain Overweight Overweight 2026-01-16
Mizuho upgrade Neutral Outperform 2026-01-13
Barclays maintain Overweight Overweight 2025-12-17
Goldman Sachs downgrade Buy Neutral 2025-12-15
Baird maintain Outperform Outperform 2025-10-28
Susquehanna maintain Neutral Neutral 2025-10-27
Barclays maintain Overweight Overweight 2025-10-24
Stifel maintain Buy Buy 2025-10-23
Barclays maintain Overweight Overweight 2025-10-03
Barclays maintain Overweight Overweight 2025-07-25
Baird maintain Outperform Outperform 2025-07-25
Truist Securities maintain Buy Buy 2025-07-25
Baird maintain Outperform Outperform 2025-05-06
Stifel maintain Buy Buy 2025-05-01
Morgan Stanley maintain Overweight Overweight 2025-04-22
Barclays maintain Overweight Overweight 2025-04-22
Goldman Sachs maintain Buy Buy 2025-04-14